FDA inspection

Polypeptide Laboratories France: FDA inspection ending May 23, 2014

FDA inspection 884800 · No Action Indicated (NAI) · Strasbourg

Key facts

Inspection ID 884800
Firm Polypeptide Laboratories France
FEI number 3007417577
Address Technopole Du Rhin, 7 Rue De Boulogne
City Strasbourg
Country France
Fiscal year 2014
Inspection end date May 23, 2014
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections